A modified subunit of mitochondrial ATPase in mutants of Saccharomyces cerevisiae with decreased sensitivity to dicyclohexylcarbodiimide  by Partis, Michael D. et al.
Volume 105, number 1 FEBSLETTERS September 1979 
A MODIFIED SUBUNIT OF MITOCHONDRIAL ATPase IN MUTANTS OF 
SACCHAROM YCES CERE VLSIAE WITH DECREASED SENSITIVITY TO 
DICYCLOHEXY LCAR~ODIIMIDE 
Michael D. PARTIS”, Enrico BERTOLIT, Edward D. ZANDERS+ and D. E. GRIFFITHS 
Department of Molecular Sciences, University of Warwick, Coventry CV4 7AL, England 
Received 4 July 1979 
1. Introduction 
Biochemical genetic studies in this laboratory have 
led to the isolation of mutants of ~~cc~~~o~~ces 
ce~e~~~~~~ with lowered sensitivity to oligomycin [ 11. 
The mutations are located on one of three loci on 
mitochondrial DNA designated OLI, OLII and OLIII 
[2,3] and may be associated with cross-resistance to 
venturicidin [3]. It has been shown that the com- 
ponent conferring lowered sensitivity resides in the 
membrane subunits of the mitochond~al ATPase and 
not in the catalytic subunits [4]. 
Dicyclohexylcarbodiimide (DCCD) is a potent 
inhibitor of oxidative phosphorylation [5] and has 
been shown to bind to a low molecular weight 
proteolipid subunit of the ox heart mitochondrial 
ATPase [6,7]. Although DCCD inhibits yeast mito- 
chondrial ATPase at low concentrations [8], the 
covalent binding of the inhibitor found in ox heart 
mitochondria cannot be demonstrated in aerobically 
grown yeast. Binding of carbodiimides to yeast 
promitochondria has been shown to be associated with 
subunit 9 of the oligomycin-sensitive ATPase [S]. We 
have investigated the physical properties of the 
carbodiimide binding protein of some oligomycin 
resistant mutants, and here present data indicating 
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that the mutation at the OLIII locus causes an 
alteration of the smallest subunit of the oligomycin 
sensitive ATPase. 
2. Materials and methods 
The parental strain of S. cerevisiue D22 (a, ada, 
a’, p’) donated by Dr D. Wilkie, and the oligomycin- 
resistant strains D22A21, D22A19 and D22A61 have 
been described f l-31. The growth on glucose 
medium [ 1 ] and isolation of mitochondria were as 
in [4], except that glucose repressed yeast was 
grown for 12 h on medium containing 5% glucose. 
Drug resistance was assayed by the drop-out technique 
[9]. Labelling of mitochondrial protein synthesis 
products was as in [lo]. Protein was determined by 
the Lowry procedure [ 111, and inorganic phosphate 
and ATPase assays were as in [4]. NCCD was in- 
corporated into yeast mitochondria as in [ 121. 
Electron paramagnetic resonance (EPR) spectra were 
recorded at room tem~rature using a Decca Radar XI 
spectrometer with a 7 in. Newport Instrument 
Magnet. 
Oligomycin sensitive ATPase was prepared as in 
[13]. Subunit 9 was prepared from submitochondrial 
particles as in [ 14], with an additional terminal step. 
Material from preparative layer c~omatography 
(TLC) in chloroform-methanol-HCl-water [14] 
was further purified by chromatography on preparative 
layer silica plates in chloroform-methanol-17% 
NHa (2: 2: 1, by vol.). Subunit 9 has an R, 0.72 in 
this system; pu~~cation was monitored with subunit 
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9 labelled with [ 3H]leucine [ lo], Isoelectric focussing 
was essentially as in [15], except that samples were. 
first solubilised in 2% SDS and 9.5 M urea. 
3. Results and discussion 
Cross-resistance of OLI, IL11 and OLIII mutants to 
DCCD at the whole cell level is shown in table I. It 
can be seen that although mutations at all 3 loci may 
give rise to lowered sensitivity to DCCD, only muta- 
tion at OLIII produces resistance in all the mutants 
examined. The resistance to oligomycin in all 
3 classes is not indicative of a common gene product; 
genetic evidence [3] shows that while OLI and OLIII 
are closely linked, OLII is located on a separate 
cistron. The cross-resistance of OLII mutants may be 
due to cooperative effects between subunits. The 
consistent resistance to DCCD found in OLIII 
mutants suggests that these mutants may be useful 
in identification of the hitherto unknown gene 
product with the carbodiimide binding site. 
Figure 1 shows that the OLIII mutation is expressed 
as a lowered sensitivity of the mitochondrial ATPase 
to DCCD. Both D22A19 and D22A61 require 
increased concentrations of DCCD for inhibition of 
the membrane bound ATPase (ZsO = 21.8 nmol/mg 
protein) compared with the parental strain (I,0 = 
1.5 nmol/mg prqtein). The same effect may be seen 
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Fig. 1. Inhibition of mitochondrial ATPase by DCCD. 
(o---o) D22 parental strain; (a- a) D2261; (0-o) 
D22A19. 
in the detergent solubilised ATPase complex (Iso 
parental strain = 5.8 nmol/mg protein, 1,, D22A19 = 
33.0 nmol/mg protein). The ATPase activity of OLI 
and OLII mutants does not, in general, show increased 
tolerance to DCCD [4]. 
N-(tetramethylpiperidinyl-l-oxyl)-N’-(cyclohexyl)- 
carbodiimide (NCCD) is a spin label analogue of 
DCCD and an equally potent inhibitor of energy- 
linked reactions [ 111. NCCD may be used as a sensitive 
monitor of the environment of the carbodiimide 
Table 1 
Resistance in Y&O to inhibitors 
Strain Mitochondrial 
locus 
_..___ 
Resistance to antibiotics in vivo (&mg) 
DCCD Oligomycin Venturicidin TET 
D22 _ 0.05 0.5 0.1 4 
D22 A21 OLI 0.05 5 0.1 4 
D22 Al6 OLI 2 5 0.1 4 
D22 Al4 OLII 2 5 0.1 4 
D22 Al5 OLII 5 5 0.1 4 
D22 C4 OLII 2 5 0.1 4 
D22 Al3 OLII 0.05 _ _ _ 
D22 B21 OLII 0.05 _ _ _ 
D22 Al9 OLIII 2 5 2 4 
D22 61 OLIII 0.5 5 2 4 
D22 62 OLIII 2 5 2 4 
D22 69 VI 2 0.5 _ 20 
The level of resistance is defined as the maximum concentration allowing normal 
growth of the strain 
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Fig.2. EPR of NCCD bound to mitochondriaJ membranes. (a) 
D22, parental strain;(b) D2261; (c) D22A19. 
binding protein. The ESR spectrum of NCCD bound 
to rnito~hond~~ membranes from glucose repressed 
parental and mutant strains is shown in fig.2 The 
spectrum of NCCD bound to mitochondrial mem- 
branes from the parental D22 strain shows the line 
broadening characteristic of an immobilised nitroxide 
spin label [l l]. It is apparent that the central peak 
height of the spectrum of NCCD bound to the 
mitochondrial membranes of the OLIH mutants 
D2261 and D22A19 is reduced compared to that of 
the parental strain, indicating a reduced affinity for 
N&CD. Moreover, the line broadening of the nitroxide 
resonance spectrum is greater in the parental strain 
compared to the OLflf mutants, which may be due to 
either a greater degree of immobilisation of the 
carbodiimide or to a more polar microenvironment 
for the binding site in the parental strain. 
In order to examine the carbodiimide binding 
protein further, the proteolipid was extracted and 
purified as in 1141, and freed from remaining lipid by 
preparative TLC in chloroform/methanol/l 7% NHs 
(2:2: 1, by vol.), The proteolipid protein, which was 
identified as a mitochondrially synthesised protein by 
~o~hromatography with 3H-labelled subunit 9, showed 
similar RF values on TLC in two systems, whether 
prepared from parental or mutant strains. Isoelectric 
focussing in polyacrylamide gel containing urea 
demonstrated that the proteolipids from parental and 
mutant strains have pl values between 4.75 and 5.0. 
The OLH mutant D22A15 contains a proteolipid 
which is indistinguishable from that of the parental 
strain, but the pf of the proteofipid of OLI mutant 
D22A2 1 and the ULIlI mutant D226t is displaced 
towards the acid, indicating amodification of these 
peptides. 
It has been shown [ 161 that the DCCD binding 
proteolipid from OLII mutants and the parental 
primarily in a low molecular weight form, while the 
proteolipids from OLH mutants and the parental 
strain exists as a 45 000 dalton aggregate which may 
be converted to the 8000 dalton form by treatment 
with base or organic solvents. The OLIII mutations 
possess the proteolipid in the aggregated 45000 dalton 
form t17f, are cross-resistant to venturi~id~ and 
DCCD f4], and are thus phenotypicafly distinct from 
the OLI mutation, although the two laci may be 
allelic 131. 
The OLIII locus has been suggested [18f as the 
structural gene for subunit 6 of the mitochondri~ 
ATPase, on the basis of decreased subunit 6 content 
in a temperature-sensitive OLIIJ mutant. However, an 
alteration of the electrophoretic mobility of subunit 
9 in this mutant has been found [ 191 and the OLIIIlocus 
suggested to play some role in the specification of this 
subunit. The consistent cross-resistance to DCCD, the 
altered ~rbodiimide binding and the change in iso- 
electric point reported here for OLIII mutants are all 
consistent with this view, 
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